Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.891,33
-4,47%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tenaya Therapeutics Inc (TNYA) Tenaya Therapeutics Inc (TNYA) Notizie

Tenaya Therapeutics Inc

TNYA
4,68
0,12 (2,63%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:16:11
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/3/202421:05GLOBETenaya Therapeutics Reports Fourth Quarter and Full Year..
18/3/202413:30GLOBETenaya Therapeutics Announces Publication of TN-401 Gene..
28/2/202401:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/2/202422:30GLOBETenaya Therapeutics to Participate in Upcoming March..
26/2/202414:30GLOBETenaya Therapeutics Announces Publication of Preclinical..
17/2/202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/2/202402:13EDGAR2Form 144 - Report of proposed sale of securities
08/2/202423:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202414:15EDGAR2Form 8-K - Current report
08/2/202414:00GLOBETenaya Therapeutics Announces Pricing of Underwritten..
31/1/202422:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/1/202414:30GLOBETenaya Therapeutics to Participate at the 42nd Annual J.P...
21/11/202322:30GLOBETenaya Therapeutics to Participate at the 35th Annual Piper..
08/11/202322:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:12EDGAR2Form 8-K - Current report
08/11/202322:05GLOBETenaya Therapeutics Reports Third Quarter 2023 Financial..
26/10/202314:30GLOBETenaya Therapeutics Announces FDA Clearance to Begin..
09/10/202314:30GLOBETenaya Therapeutics Presents Encouraging New Clinical and..
05/10/202314:30GLOBETenaya Therapeutics Doses First Patient in the MyPeak-1™..
02/10/202323:30GLOBETenaya Therapeutics Publishes Preclinical Data in..
21/9/202322:05GLOBETenaya Therapeutics to Present Data for TN-301 and TN-201 at..
31/8/202322:05GLOBETenaya Therapeutics to Participate at the 21st Annual Morgan..
19/8/202300:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/8/202303:10EDGAR2Form 144 - Report of proposed sale of securities
09/8/202322:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:19EDGAR2Form 8-K - Current report
09/8/202322:05GLOBETenaya Therapeutics Reports Second Quarter 2023 Financial..
02/8/202322:05GLOBETenaya Therapeutics to Participate at the 43rd Annual..
10/5/202322:19GLOBETenaya Therapeutics Reports First Quarter 2023 Financial..
03/5/202314:00GLOBETenaya Highlights Growing Capabilities in AAV Manufacturing,..
02/5/202314:43DJNTenaya Therapeutics Gets FDA Fast-Track Designation for..
02/5/202313:50GLOBETenaya Therapeutics Receives FDA Fast Track Designation for..
Apertura: 4,58 Min: 4,47 Max: 4,81
Chiusura: 4,56

La tua Cronologia

NASDAQ
TNYA
Tenaya Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network